Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First Recurrence of Ovarian Cancer”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Testing effectiveness (Phase 2)Study completedNCT00318370
What this trial is testing

Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Neoplasms
Morphotek 58
Testing effectiveness (Phase 2)Ended earlyNCT00005612
What this trial is testing

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer

Who this might be right for
Ovarian Cancer
H. Lee Moffitt Cancer Center and Research Institute 3
Testing effectiveness (Phase 2)Ended earlyNCT01018563
What this trial is testing

An Open Label Extension Study of the Efficacy of MORAb-003

Who this might be right for
Epithelial Ovarian Cancer
Morphotek 3
Testing effectiveness (Phase 2)Ended earlyNCT00888810
What this trial is testing

Efficacy of Topotecan and Lapatinib in Early Recurrent Ovarian or Peritoneal Cancer

Who this might be right for
CancerOvarianRelapse+1 more
Centre Francois Baclesse 39
Testing effectiveness (Phase 2)Study completedNCT00217568
What this trial is testing

Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity Cancer

Who this might be right for
Ovarian CancerPeritoneal Cavity Cancer
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03345485
What this trial is testing

Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.

Who this might be right for
Small Cell Lung CancerSoft Tissue SarcomaTriple-negative Breast Cancer+2 more
Mundipharma Research Limited 71
Early research (Phase 1)Study completedNCT01281514
What this trial is testing

Carboplatin, PLD and Everolimus in Certain Gynecologic Cancer

Who this might be right for
Fallopian Tube CancerPeritoneal Cavity CancerRecurrent Ovarian Epithelial Cancer
Fox Chase Cancer Center 21
Early research (Phase 1)Study completedNCT02054351
What this trial is testing

Phase 1 Trial of IMAB027 in Patients With Recurrent Advanced Ovarian Cancer (OVAR)

Who this might be right for
Ovarian Cancer
Ganymed Pharmaceuticals GmbH 42
Not applicableNot Yet RecruitingNCT07153705
What this trial is testing

OCS Products Based on Exosome Technology Were Applied in the Recurrence Monitoring Study After the Initial Treatment of Baseline CA125-negative Ovarian Cancer

Who this might be right for
Ovarian Cancer
Beihua Kong 32
Early research (Phase 1)Looking for participantsNCT06799065
What this trial is testing

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

Who this might be right for
Advanced Solid TumorsBreast Cancer RecurrentOvarian Cancer+2 more
Accent Therapeutics 90
Testing effectiveness (Phase 2)WithdrawnNCT00408967
What this trial is testing

Determine if Either of 2 Doses of Study Drug Given With a Low-dose of Cyclophosphamide After a Complete or Partial Response to a Platinum-based Second-line Therapy in Women With Recurrent Ovarian Carcinoma Results in a Longer Time to Progression When Compared to the First Time to Progression.

Who this might be right for
Ovarian Cancer
EMD Serono
Early research (Phase 1)Study completedNCT03507452
What this trial is testing

First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin

Who this might be right for
Advanced Recurrent Malignant Pleural Epithelioid MesotheliomaAdvanced Recurrent Malignant Peritoneal Epithelioid MesotheliomaAdvanced Recurrent Serous Ovarian Cancer+1 more
Bayer 36
Early research (Phase 1)Looking for participantsNCT06515613
What this trial is testing

CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

Who this might be right for
Platinum-resistant Ovarian CancerTesticular CancerEndometrial Cancer
Context Therapeutics Inc. 156
Testing effectiveness (Phase 2)UnknownNCT05965141
What this trial is testing

Aribulin Combined With Carboplatin and Bevacizumab in the Treatment of Ovarian Cancer

Who this might be right for
Ovarian Cancer
Second Affiliated Hospital of Guangzhou Medical University 38
Not applicableEnded earlyNCT07000344
What this trial is testing

Apatinib Combined With Letrozole With or Without Fluzoparib in Estrogen Receptor-Positive, Platinum-Sensitive Recurrent Ovarian Cancer Previously Treated With First-Line PARP Inhibitor

Who this might be right for
Ovarian Cancer
Peking Union Medical College Hospital 5
Early research (Phase 1)Study completedNCT06108479
What this trial is testing

Study of DF6215 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultSolid Tumor Cancer
Dragonfly Therapeutics 35
Not applicableUnknownNCT01539785
What this trial is testing

Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) in Ovarian Cancer Recurrence

Who this might be right for
First Recurrence of Ovarian Cancer
Catholic University of the Sacred Heart 158
Testing effectiveness (Phase 2)Study completedNCT00780039
What this trial is testing

Evaluate the Safety and Efficacy of Caelyx in Combination With Carboplatin in Patients With Ovarian Cancer Recurrent Within Six to Twelve Months After Initial Carboplatin and Paclitaxel Chemotherapy (P03625)

Who this might be right for
Ovarian Neoplasms
Merck Sharp & Dohme LLC 58
Early research (Phase 1)Study completedNCT00132522
What this trial is testing

EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide

Who this might be right for
Ovarian CancerColorectal CancerCarcinoma, Non-small-cell Lung+1 more
EMD Serono 45
Large-scale testing (Phase 3)UnknownNCT03220932
What this trial is testing

Cytoreductive Surgery and HIPEC in First or Secondary Platinum-resistant Recurrent Ovarian Epithelial Cancer

Who this might be right for
Ovarian Epithelial Cancer
Hospices Civils de Lyon 132
Load More Results